200 related articles for article (PubMed ID: 3530186)
1. The clinical significance of the in vivo antinuclear antibody phenomenon.
Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
[TBL] [Abstract][Full Text] [Related]
2. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
[TBL] [Abstract][Full Text] [Related]
3. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
[TBL] [Abstract][Full Text] [Related]
4. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
5. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
Morel P; Allègre P; Civatte J
Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
[TBL] [Abstract][Full Text] [Related]
6. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
7. [Immunologic characterization of autoreactivity to nuclear antigens in patients with systemic lupus erythematosus].
Lenert P; Felle D; Lenert G; Mitić I; Curić S; Vodopivec S; Tepavcević P
Med Pregl; 1993; 46(5-6):167-72. PubMed ID: 7869968
[TBL] [Abstract][Full Text] [Related]
8. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
Watanabe S; Miyawaki S
Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
[No Abstract] [Full Text] [Related]
9. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
10. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
11. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
Lee TK; Rothberger H
Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
Landry M; Sams WM
J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
[TBL] [Abstract][Full Text] [Related]
14. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
[TBL] [Abstract][Full Text] [Related]
15. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
16. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
17. [Anti-ENA antibody and nephropathy--cases of MCTD and SLE].
Yoshida A; Shinmura I; Morozumi K; Oikawa T; Fujinami T; Matsumoto Y; Nakamura S; Gotoh I; Sohmiya S
Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):221-8. PubMed ID: 3488441
[No Abstract] [Full Text] [Related]
18. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies heralding the onset of systemic lupus erythematosus.
Aho K; Koskela P; Mäkitalo R; Heliövaara M; Palosuo T
J Rheumatol; 1992 Sep; 19(9):1377-9. PubMed ID: 1433004
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of antinuclear antibodies.
Meryhew NL; Messner RP; Tan EM
J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
